SCHEMBL19334476

SCHEMBL19334476

CCNc1cc(C(=O)O)c(C(=O)O)cc1[N+](=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR3 P49019 4/20 0.47
▸ MAPT P10636 8/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ PLEC Q15149 1/20 0.41
▸ FABP4 P15090 1/20 0.36
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPK1 P28482 2/20 0.33
▸ CLCN2 P51788 1/20 0.33
▸ DCTPP1 Q9H773 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401684 0.85 HCAR3 (0.64) HCAR3MAPTALDH1A1GAAHPGD
SCHEMBL16406364 0.77 HCAR3 (0.36) HCAR3MAPTKDM4EALDH1A1HTT
SCHEMBL9944765 0.74 HCAR3 (0.58) HCAR3MAPTALDH1A1GAAHPGD
SCHEMBL19334478 0.72 MAPT (0.53) HCAR3MAPTKDM4EALDH1A1GAA
SCHEMBL15636591 0.67 KDM4E (0.44) HCAR3MAPTKDM4EALDH1A1GAA
SCHEMBL30309524 0.67 MAPT (0.57) HCAR3MAPTALDH1A1GAAHTT
SCHEMBL9206969 0.67 MAPT (0.57) HCAR3MAPTALDH1A1GAAHTT
SCHEMBL4211532 0.67 KMT2A (0.72) HCAR3MAPTALDH1A1GAAHTT
SCHEMBL184136 0.66 ALDH1A1 (0.62) KDM4EALDH1A1HPGDFABP4KMT2A
SCHEMBL17938290 0.66 ALDH1A1 (0.63) HCAR3MAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 — — US disclosed
Send feedback